Skip to main content

Table 1 Inclusion and exclusion criteria

From: The clinical effect of arrhythmia monitoring after myocardial infarction (BIO-GUARD|MI):study protocol for a randomized controlled trial

Inclusion criteria
 History of MI according to guidelines:
  CHA2DS2-VASc score ≥ 4 in men/≥ 5 in women
  LVEF > 35% as estimated within 6 months before enrollment but after conclusion of acute MI treatment
  Patient accepts activation of home monitoring
  Patient has provided written informed consent
Exclusion criteria
 Platelet count < 90,000 per mm3 or patients with hemorrhagic diathesis
 Permanent oral anticoagulation treatment for atrial fibrillation
 Indication for chronic renal dialysis
 Pacemaker or ICD implanted or indication for implantation
 Parkinson’s disease
 Life expectancy < 1 year
 Participation in another interventional clinical investigation during the course of the study, i.e. the participation in a noninterventional clinical investigation is allowed.
 Age < 18 years
 Woman who are pregnant or breast feeding
  1. ICD implantable cardioverter-defibrillator, LVEF left ventricular ejection fraction, MI myocardial infarction